Nyxoah (NYXH) said Wednesday it launched its Genio neurostimulator system in the Netherlands, with the first successful implants done at OLVG West in Amsterdam and Zuyderland Hospital in Heerlen in patients with obstructive sleep apnea.
Shares were nearly 9% higher in premarket trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.